Neurocrine Biosciences
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
3/10
|
51.96 | 57.27 | -9.27% | 105.61 | -50.81% |
| P/S |
|
6.87 | 33.44 | -79.44% |
|
|
| P/BV |
|
5.81 | 4.64 | 25.18% |
|
|
| P/FCF |
|
28.87 | 42.53 | -32.12% |
|
|
| Ev/Ebitda |
|
31.6 | -17.68 | -278.8% |
|
|
| Ev/S |
|
6.97 | 22.59 | -69.16% |
|
|
| Ev/FCF |
|
36.37 | 47.55 | -23.51% |
|
|
| E/P |
|
0.0239 | 0.0182 | 31.32% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
22.05 | -14.2 | -255.24% | 21.69 | +1.67% |
| ROE |
|
11.19 | 9.78 | 14.36% |
|
|
| ROA |
|
7.68 | 0.33 | 2226.86% |
|
|
| ROIC |
|
5.01 | 7.63 | -34.38% |
|
|
| ROS |
|
13.23 | -26.41 | -150.09% |
|
|
| ROCE |
|
17.69 | 14.55 | 21.59% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
8/10
|
1.03 | -3.87 | -126.58% | 1.27 | -19.17% |
| Nеt Debt/Ebitda |
|
0.4261 | -4.24 | -110.05% |
|
|
| Debt/Ratio |
|
0.1318 | 0.1853 | -28.89% |
|
|
| Debt/Equity |
|
7.31 | 1.61 | 355.06% |
|
|
| Debt/Net Income |
|
1.72 | 10.06 | -82.95% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2368 | -100% |
|
|
| Average dividend growth |
|
0 | 1.48 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4863 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
139.45 | 30.62 | 355.42% | ||
| Growth impulse Ebitda in 5 years |
|
57.99 | -17.42 | -432.89% | ||
| Growth impulse Net Income in 5 years |
|
574.86 | -52.26 | -1200% | ||
| Growth impulse FCF in 5 years |
|
163.36 | -31.68 | -615.66% | ||
| Growth impulse EPS in 5 years |
|
539.49 | -61.82 | -972.68% |
IP Score
5.03/10
